Cardinal Health has announced the US launch of its Kendall SCD SmartFlow Compression System, the next generation of the Kendall Compression Series offering an enhanced clinician and patient experience. Featuring clinically proven technology that delivers customised, intermittent pneumatic compression (IPC) to increase blood flow in at-risk patients, the Kendall SCD SmartFlow System is designed to help prevent venous thromboembolism (VTE) events, as well as enhance blood circulation and treat pain and swelling related to venous stasis.
“We’re proud to introduce the reimagined Kendall SCD device to our customers for consistent, effective and reliable compression therapy, providing clinicians with efficiencies so they can focus more of their time on direct patient care,” said Steve Marshall, Senior Vice President, Cardinal Health Global Product Marketing. “We’re happy to offer an easy-to-use device that now has the indication to treat pain and swelling, which can be common and debilitating symptoms for patients with insufficient blood flow.”
The Kendall SCD SmartFlow Compression System leverages Vascular Refill Detection (VRD) technology with a sequential, gradient and circumferential sleeve design to move more blood per hour than uniform compression. The VRD technology adjusts and customises compression cycles to match a patient’s unique vascular refill time, helping the patient receive more compression cycles over time and ultimately reducing stasis. The circumferential sleeve design allows therapy to be applied regardless of sleeve and tubing position, while the gradient pressure pattern maximises blood flow.